61 related articles for article (PubMed ID: 20306032)
1. Pneumorrhachis With FDG Uptake Cervical Lesions on PET/CT of a Patient With Suspected Recurrent Hypopharyngeal Cancer.
Huang YE; Chuang CL; Wu SH; Chang YM; Kao PF
Clin Nucl Med; 2024 May; 49(5):462-463. PubMed ID: 38466017
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the cervix uteri: 2021 update.
Bhatla N; Aoki D; Sharma DN; Sankaranarayanan R
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):28-44. PubMed ID: 34669203
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/computed tomography scan in patients with suspicion of recurrent neuroendocrine carcinoma of the cervix.
Jiang Y; Hou G; Huo L; Li F; Zhu Z; Cheng W
Nucl Med Commun; 2021 Oct; 42(10):1151-1156. PubMed ID: 33927154
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Combining
Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
[No Abstract] [Full Text] [Related]
5. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
6. The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma.
Chang KJ; Lim I; Park JY; Jo AR; Kong CB; Song WS; Jo WH; Lee SY; Koh JS; Kim BI; Choi CW; Lim SM
Nucl Med Mol Imaging; 2015 Mar; 49(1):33-41. PubMed ID: 25774236
[TBL] [Abstract][Full Text] [Related]
7. Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer.
Hu YY; Fan W; Zhang X; Liang PY; Lin XP; Zhang YR; Li YH
J Cancer; 2015; 6(3):287-91. PubMed ID: 25663947
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis.
Xiao Y; Wei J; Zhang Y; Xiong W
Arch Med Sci; 2014 May; 10(2):222-31. PubMed ID: 24904653
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for 2-[(18)F] fluoro-2-deoxy-D-glucose PET/CT in cervical-vaginal neuroendocrine carcinoma: case series and literature review.
Lin Y; Lin WY; Liang JA; Lu YY; Wang HY; Tsai SC; Kao CH
Korean J Radiol; 2012; 13(6):760-70. PubMed ID: 23118575
[TBL] [Abstract][Full Text] [Related]
10. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Pan L; Cheng J; Zhou M; Yao Z; Zhang Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.
Chu Y; Zheng A; Wang F; Lin W; Yang X; Han L; Chen Y; Bai L
Nucl Med Commun; 2014 Feb; 35(2):144-50. PubMed ID: 24177043
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of recurrent uterine cervical cancer: PET versus PET/CT: a systematic review and meta-analysis.
Ding XP; Feng L; Ma L
Arch Gynecol Obstet; 2014 Oct; 290(4):741-7. PubMed ID: 24798933
[TBL] [Abstract][Full Text] [Related]
14. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Pallardy A; Bodet-Milin C; Oudoux A; Campion L; Bourbouloux E; Sagan C; Ansquer C; Testard A; Resche I; Bridji B; Kraeber-Bodéré F; Rousseau C
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1270-8. PubMed ID: 20306032
[TBL] [Abstract][Full Text] [Related]
15. Clarifying the diagnosis of clinically suspected recurrence of cervical cancer: impact of 18F-FDG PET.
van der Veldt AA; Buist MR; van Baal MW; Comans EF; Hoekstra OS; Molthoff CF
J Nucl Med; 2008 Dec; 49(12):1936-43. PubMed ID: 18997039
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
Chung HH; Jo H; Kang WJ; Kim JW; Park NH; Song YS; Chung JK; Kang SB; Lee HP
Gynecol Oncol; 2007 Mar; 104(3):529-34. PubMed ID: 17049971
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
